Page last updated: 2024-08-05 12:16:32

organic heterooctacyclic compound

null

ChEBI ID: 38165

Members (6)

MemberDefinitionRole
kt 5720An organic heterooctacyclic compound that is 1H,1'H-2,2'-biindole in which the nitrogens have undergone formal oxidative coupling to positions 2 and 5 of hexyl (3S)-3-hydroxy-2-methyltetrahydrofuran-3-carboxylate (the 2R,3S,5S product), and in which the 3 and 3' positions of the biindole moiety have also undergone formal oxidative coupling to positions 3 and 4 of 1,5-dihydro-2H-pyrrol-2-one.KT 5720
kt 5823An organic heterooctacyclic compound that is 1H,1'H-2,2'-biindole in which the nitrogens have undergone formal oxidative coupling to positions 2 and 5 of methyl (3R)-3-methoxy-2-methyltetrahydrofuran-3-carboxylate (the 2S,3R,5R product), and in which the 3 and 3' positions of the biindole moiety have also undergone formal oxidative coupling to positions 3 and 4 of 1-methyl-1,5-dihydro-2H-pyrrol-2-one.KT 5823
kt 5926An organic heterooctacyclic compound that is 5-propoxy-1H,1'H-2,2'-biindole in which the nitrogens have undergone formal oxidative coupling to positions 2 and 5 of methyl (3R)-3-hydroxy-2-methyltetrahydrofuran-3-carboxylate (the 2S,3R,5R product), and in which the 3 and 3' positions of the biindole moiety have also undergone formal oxidative coupling to positions 3 and 4 of 1,5-dihydro-2H-pyrrol-2-one.KT 5926
midostaurinAn organic heterooctacyclic compound that is the N-benzoyl derivative of staurosporine.midostaurin
sf 2370A organic heterooctacyclic compound that is a potent inhibitor of protein kinase C and is isolated from Nocardiopsis sp K-252aK-252a
staurosporinestaurosporine

Research

Studies (1,588)

TimeframeStudies, Drugs in This Class (%)All Drugs %
pre-19904 (0.25)18.7374
1990's279 (17.57)18.2507
2000's550 (34.63)29.6817
2010's561 (35.33)24.3611
2020's194 (12.22)2.80

Study Types

Publication TypeStudies, Drugs in This Class (%)All Drugs (%)
Trials37 (2.21%)5.53%
Reviews103 (6.16%)6.00%
Case Studies31 (1.85%)4.05%
Observational2 (0.12%)0.25%
Other1,499 (89.65%)84.16%